Yu Herbert, Shu Xiao-Ou, Shi Runhua, Dai Qi, Jin Fan, Gao Yu-Tang, Li Benjamin D L, Zheng Wei
Department of Epidemiology and Public Health and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8034, USA.
Int J Cancer. 2003 May 20;105(1):92-7. doi: 10.1002/ijc.11034.
Estrogens regulate the growth and differentiation of mammary cells and play an important role in the development of breast cancer. High circulating levels of estrogens are associated with increased risk of breast cancer in Caucasian women. Because Asian women have low estrogens in the circulation compared with their Caucasian counterparts, the effect of estrogens on breast cancer risk in populations with low circulating estrogens remains to be elucidated. We conducted a population-based case-control study in China to evaluate the association of sex steroid hormones with breast cancer risk in Chinese women. Our study included 300 incident cases with primary breast cancer and 300 age- and menopausal status-matched healthy controls randomly selected from the general population in Shanghai. Fasting blood samples were collected from cases prior to any treatment and from their matched controls. Commercial immunoassays were used to measure plasma concentrations of estradiol, estrone, estrone sulfate, testosterone, progesterone, dehydroepiandrosteindian sulfate (DHEA-S) and steroid hormone-binding globulin (SHBG). Conditional logistic regression analysis was performed to examine the association between steroid hormones and breast cancer risk. The results showed that breast cancer risk was elevated with increasing levels of estrone and testosterone (p for trend < 0.05) but not with DHEA-S, estradiol, estrone sulfate, progesterone or SHBG. The estimated relative risks between upper and lower tertiles were 2.07 (95% confidence interval [CI] 0.97-4.41) for estrone in postmenopausal women, 2.01 (95% CI 0.96-4.21) for testosterone in premenopausal women, and 2.40 (95% CI 1.11-5.21) for testosterone in postmenopausal women, after adjusting for age at first live birth, waist-to-hip ratio, total calorie intake, a history of fibroadenoma, a family history of breast cancer and SHBG. These results, in general, are consistent with the findings in Caucasian women and indicate that high sex steroid hormones in the circulation, both androgen and estrogen, are associated with increased risk of breast cancer even in populations with relatively low sex hormones.
雌激素调节乳腺细胞的生长和分化,在乳腺癌的发生发展中起重要作用。白种女性中,循环中雌激素水平升高与乳腺癌风险增加相关。由于与白种女性相比,亚洲女性循环中的雌激素水平较低,雌激素对循环雌激素水平低的人群患乳腺癌风险的影响仍有待阐明。我们在中国进行了一项基于人群的病例对照研究,以评估性类固醇激素与中国女性乳腺癌风险的关联。我们的研究纳入了300例原发性乳腺癌新发病例以及300例年龄和绝经状态匹配的健康对照,这些对照是从上海普通人群中随机选取的。在病例接受任何治疗之前,采集其空腹血样,并采集与之匹配的对照的血样。使用商业免疫测定法测量血浆中雌二醇、雌酮、硫酸雌酮、睾酮、孕酮、硫酸脱氢表雄酮(DHEA-S)和类固醇激素结合球蛋白(SHBG)的浓度。进行条件逻辑回归分析以检验类固醇激素与乳腺癌风险之间的关联。结果显示,随着雌酮和睾酮水平升高,乳腺癌风险增加(趋势p<0.05),但与DHEA-S、雌二醇、硫酸雌酮、孕酮或SHBG无关。在调整首次生育年龄、腰臀比、总热量摄入、纤维腺瘤病史、乳腺癌家族史和SHBG后,绝经后女性中雌酮的上三分位数与下三分位数之间的估计相对风险为2.07(95%置信区间[CI]0.97-4.41),绝经前女性中睾酮的估计相对风险为2.01(95%CI0.96-4.21),绝经后女性中睾酮的估计相对风险为2.40(95%CI1.11-5.21)。总体而言,这些结果与白种女性的研究结果一致,表明即使在性激素水平相对较低的人群中,循环中的高性类固醇激素,包括雄激素和雌激素,也与乳腺癌风险增加相关。